These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28574002)

  • 21. Vogt-Koyanagi-Harada disease, diabetes mellitus, and psoriasis in a child.
    Ojaimi E; Levy J; Stawell R; Van Heerden A; Godfrey T; Zamir E
    Ocul Immunol Inflamm; 2012 Feb; 20(1):56-8. PubMed ID: 22188226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
    Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
    Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vogt Koyanagi Harada Syndrome mimicking multiple sclerosis: A case report and review of the literature.
    Algahtani H; Shirah B; Algahtani R; Alkahtani A; Alwadie S
    Mult Scler Relat Disord; 2017 Feb; 12():44-48. PubMed ID: 28283106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease.
    Jiang S; Liu X; Luo L; Qu B; Huang X; Xu L; Lin Y; Ye S; Liu Y
    Br J Ophthalmol; 2010 Aug; 94(8):1078-82. PubMed ID: 19910285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Headache as a first manifestation of Vogt-Koyanagi-Harada disease.
    Kosma KK; Kararizou E; Markou I; Eforakopoulou E; Kararizos G; Mitsonis C; Gkiatas K
    Med Princ Pract; 2008; 17(3):253-4. PubMed ID: 18408397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography/computed tomography scan of Vogt-Koyanagi-Harada syndrome with associated autoimmune thyroid disease: A case report and literature review.
    Huang KH; Tai MC; Lee LC; Weng TH; Chen YH; Lin LF; Chen JT; Lu DW; Chen CL
    Medicine (Baltimore); 2018 Mar; 97(9):e0047. PubMed ID: 29489658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of pachymeningeal enhancement in Vogt-Koyanagi-Harada disease.
    Han HJ; Kim HY; Park JH; Lee EJ; Kim DG; Shin DI
    Neurol Sci; 2010 Dec; 31(6):785-8. PubMed ID: 20198496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratympanic steroid use for hearing salvage in Vogt-Koyanagi-Harada syndrome.
    Pelosi S; Chandrasekhar SS
    Ear Nose Throat J; 2011 Dec; 90(12):574-7. PubMed ID: 22180111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.
    Cuevas M; de-la-Torre A; Córdoba A
    Ocul Immunol Inflamm; 2018; 26(7):1101-1106. PubMed ID: 28548582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An association between Vogt-Koyanagi-Harada disease and Guillain-Barré syndrome.
    Najman-Vainer J; Levinson RD; Graves MC; Nguyen BT; Engstrom RE; Holland GN
    Am J Ophthalmol; 2001 May; 131(5):615-9. PubMed ID: 11336936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report.
    Niidome S; Usui Y; Tsubota K; Sugawara R; Goto H
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1305-1309. PubMed ID: 37084286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Presentation, Management, and Long-Term Outcome of Pars Planitis, Panuveitis, and Vogt-Koyanagi-Harada Disease in Children and Adolescents.
    Reiff A
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1589-1596. PubMed ID: 31444859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vogt-koyanagi-harada disease with onset in elderly patients aged 68 to 89 years.
    Yamamoto Y; Fukushima A; Nishino K; Koura Y; Komatsu T; Ueno H
    Jpn J Ophthalmol; 2007; 51(1):60-3. PubMed ID: 17295144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.
    Sato T; Nihei R; Sora D; Nishio Y; Takeuchi M
    Front Immunol; 2022; 13():967972. PubMed ID: 36248859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral ischemic involvement in Vogt-Koyanagi-Harada disease.
    Vergaro R; Cordelli DM; Miniaci A; Tassinari D; Spinardi L; Pession A; Franzoni E
    Pediatr Neurol; 2014 Jul; 51(1):119-22. PubMed ID: 24830768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vogt-Koyanagi-Harada syndrome and ulcerative colitis.
    Federman DG; Kravetz JD; Ruser CB; Judson PH; Kirsner RS
    South Med J; 2004 Feb; 97(2):169-71. PubMed ID: 14982267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vogt-Koyanagi-Harada syndrome and mesenteric ischemia: a case report.
    Anadol AZ; Akin M; Kurukahvecioglu O; Ersoy E
    Adv Ther; 2007; 24(4):863-7. PubMed ID: 17901035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successive onset of Vogt-Koyanagi-Harada syndrome in father and son.
    Li H; Sun S; Zhang Y; Liu J; Zhao X; Zhao G
    BMC Ophthalmol; 2023 Mar; 23(1):113. PubMed ID: 36944975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Vogt-Koyanagi-Harada syndrome: a rare differential diagnosis of uveitis in childhood. A case report taking into account the revised diagnostic criteria].
    Rieger R; Keitzer R; Pleyer U
    Klin Monbl Augenheilkd; 2005 Nov; 222(11):919-22. PubMed ID: 16308827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A challenged case of Vogt-Koyanagi-Harada syndrome: when dermatological manifestations came first.
    Coutinho I; Pedrosa C; Santos C; Pina S; Lisboa M; Bernardo M; Prieto I
    Int Ophthalmol; 2018 Apr; 38(2):793-798. PubMed ID: 28361380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.